| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/21/2001 | CN1323186A Two chamber cartridge for atomizers |
| 11/21/2001 | CN1323170A Nutritional and pharmaceutical compositions |
| 11/21/2001 | CN1322564A Red wound plaster for treating bone fracture |
| 11/21/2001 | CN1322563A Zhengtang capsule for treating diabetes |
| 11/21/2001 | CN1322562A Chinese medicine plaster for treating hyperosteogeny and its preparation |
| 11/21/2001 | CN1322559A Externally applied sterility plaster |
| 11/21/2001 | CN1322554A Cream for treating burns, scalds and sore ulcer and its preparation |
| 11/21/2001 | CN1322523A External-use Mayroxicam gel agent and its preparation |
| 11/21/2001 | CN1322474A Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process |
| 11/21/2001 | CN1074932C Ophthalmic compositions |
| 11/21/2001 | CN1074927C Active medical component of 'Duanshepiju' its extraction process and medicine containing the same |
| 11/21/2001 | CN1074923C Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 11/21/2001 | CN1074922C Oral liquid composition containing paroxetine resinate |
| 11/21/2001 | CN1074917C Stable carotenoid emulsions adapted for parenteral administration |
| 11/20/2001 | US6320017 Polyamide oligomers |
| 11/20/2001 | US6319945 Applying ivermectin lotion or cream daily for 7 days and repeating such application one to four times per month for a period of several months. |
| 11/20/2001 | US6319943 Oral formulation for paclitaxel |
| 11/20/2001 | US6319927 Method of using levocetirizine and pharmaceutical compositions containing the same for inducing sleep |
| 11/20/2001 | US6319913 Penetration enhancing and irritation reducing systems |
| 11/20/2001 | US6319904 Useful as an antiulcer agent, showing potent anti-helicobacter pylori activity |
| 11/20/2001 | US6319896 Adding aqueous solution of charged polymer to solution of purified protein to reduce intermolecular or intramolecular interactions between the positively and negatively charged domains whereby solubility of protein is increased |
| 11/20/2001 | US6319895 Is disintegrated during transportation and does not adhere to the inner wall of oral cavity upon taking; hardness |
| 11/20/2001 | US6319698 Method for producing arachidonic acid |
| 11/20/2001 | US6319541 Selectively accumulating electrostatic charge, charging the particles promoting adherence, exposing to a cloud of the charged particles of the medicament; accuracy |
| 11/20/2001 | US6319521 Exposing to a compressed antisolvent(carbon dioxide); controlled release |
| 11/20/2001 | US6319520 Copolymers of ammonium methacrylate that consist of fully polymerized copolymers of acrylic acid and methacrylic acid ester having quaternary ammonium groups |
| 11/20/2001 | US6319519 Anti-inflammatory pharmaceutical formulations |
| 11/20/2001 | US6319518 Colon selective drug delivery composition |
| 11/20/2001 | US6319517 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation |
| 11/20/2001 | US6319516 Lipophilic group, linker bond, spacer arm and a cationic amino group; stability; |
| 11/20/2001 | US6319515 Isosorbide dinitrate-containing patch |
| 11/20/2001 | US6319513 Oral liquid mucoadhesive compounds |
| 11/20/2001 | US6319512 Implants for controlled release of pharmaceutically active principles and method for making same |
| 11/20/2001 | US6319510 Pad to be installed on gum comprising nonporous layer, adjacent layer retaining medication capable of being liquefied by saliva, semipermeable layer covering second layer and sealed to first layer to form pocket enclosing second layer |
| 11/20/2001 | US6319509 Pharmaceutical composition |
| 11/20/2001 | US6319492 Copolymers of tyrosine-based polyarylates and poly(alkylene oxides) |
| 11/20/2001 | US6319490 Liquid oral compositions comprising a calcium compound and an acidulant |
| 11/20/2001 | US6319464 Added to borate containing compound; antimicrobial activity enhancement |
| 11/20/2001 | US6319260 Method of endoscopic mucosal resection using mucopolysaccharide and local injection preparation |
| 11/20/2001 | US6319226 Implantable vascular access device |
| 11/20/2001 | US6318650 Method for producing small-particle preparations of biologically active substances |
| 11/20/2001 | CA2257431C Fast-dissolving galanthamine hydrobromide tablet |
| 11/20/2001 | CA2229279C Nutritional and/or dietary composition and method of using the same |
| 11/20/2001 | CA2167383C Ophthalmic solution based on diclofenac and tobramycine and its applications |
| 11/20/2001 | CA2090404C Nonaqueous fluorinated drug delivery vehicle suspensions |
| 11/20/2001 | CA2086121C Ophthalmic suspensions |
| 11/20/2001 | CA2059221C Feed additive for ruminants |
| 11/20/2001 | CA2058946C Formulations for the oral administration of drugs with masked taste |
| 11/20/2001 | CA2046679C Pharmaceutical composition for rapid suspension in water |
| 11/20/2001 | CA2017851C Micronised biodegradable particles, process for preparing them and the use thereof |
| 11/18/2001 | CA2345482A1 Use of paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors and the drug obtained thereby |
| 11/15/2001 | WO2001086756A1 Coaxial connector having detachable locking sleeve |
| 11/15/2001 | WO2001085845A1 Wound gels |
| 11/15/2001 | WO2001085836A1 Gel comprised of a poly-$g(a)-1,4-glucan and starch |
| 11/15/2001 | WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 11/15/2001 | WO2001085668A1 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them |
| 11/15/2001 | WO2001085437A1 Process and press for the production of tablets |
| 11/15/2001 | WO2001085417A1 Method of producing structures using centrifugal forces |
| 11/15/2001 | WO2001085345A1 Media milling |
| 11/15/2001 | WO2001085257A2 Opioid antagonist compositions and dosage forms |
| 11/15/2001 | WO2001085218A2 Acylated cyclodextrin guest inclusion complexes |
| 11/15/2001 | WO2001085217A1 Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 11/15/2001 | WO2001085216A1 Method for the preparation of polymeric micelle via phase separation of block copolymer |
| 11/15/2001 | WO2001085184A2 Nontoxic vernix compositions and method of producing |
| 11/15/2001 | WO2001085181A1 Therapeutical composition comprising iodine tincture, alcohol and castor oil for treatment of psoriasis |
| 11/15/2001 | WO2001085176A1 The solid oral pharmaceutical composition comprising a bisphosphonic acid derivative |
| 11/15/2001 | WO2001085174A1 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases |
| 11/15/2001 | WO2001085156A1 Dermal compositions containing coenzyme q as the active ingredient |
| 11/15/2001 | WO2001085150A2 Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists |
| 11/15/2001 | WO2001085148A2 Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride |
| 11/15/2001 | WO2001085147A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF |
| 11/15/2001 | WO2001085143A2 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents |
| 11/15/2001 | WO2001085142A1 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 11/15/2001 | WO2001085141A1 β-GLUCANS ENCAPSULATED IN LIPOSOMES |
| 11/15/2001 | WO2001085140A1 Evaporative coolant comprising hydrofluorocarbons and/or hydrochlorofluorocarbons |
| 11/15/2001 | WO2001085138A2 Particulate encapsulation of liquid beads |
| 11/15/2001 | WO2001085137A2 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 11/15/2001 | WO2001085136A2 Phospholipid-based powders for drug delivery |
| 11/15/2001 | WO2001085135A1 PHARMACEUTICAL COMPOSITION CONTAINING ITRACONAZOLE WITH GASTRIC pH-INDEPENDENTLY IMPROVED SOLUBILITY AND PREPARATION METHOD THEREOF |
| 11/15/2001 | WO2001085134A1 Pharmaceutical solid compositions and process for the production of mouth dissolving tablets |
| 11/15/2001 | WO2001085133A1 Drug delivery device, especially for the delivery of gestodene |
| 11/15/2001 | WO2001085132A1 Drug delivery device, especially for the delivery of levonorgestrel |
| 11/15/2001 | WO2001085131A2 Lipid carrier compositions for improved drug retention |
| 11/15/2001 | WO2001085128A2 Skin protectant spray compositions |
| 11/15/2001 | WO2001085109A1 Novel quaternary compounds, compositions containing them, and uses thereof |
| 11/15/2001 | WO2001085099A2 Polymeric delivery and release systems for oral care actives |
| 11/15/2001 | WO2001085093A2 Compounds and methods for modulating cerebral amyloid angiopathy |
| 11/15/2001 | WO2001084963A1 Edible composition containing micronised nacre powder |
| 11/15/2001 | WO2001058427A8 Particulate composition, method for producing said composition and use of the same |
| 11/15/2001 | WO2001047498A3 Hydrogel-driven layered drug dosage form comprising sertraline |
| 11/15/2001 | WO2001041733A3 Compressed tablet composition comprising a nsaid |
| 11/15/2001 | WO2001036656A3 A complex between hyaluronic acid and a biomolecule and its use |
| 11/15/2001 | WO2001019334A3 Pharmaceutical solutions of levosimendan |
| 11/15/2001 | WO2001017567A3 Improved container composition for diagnostic agents |
| 11/15/2001 | WO2000064484A3 Conjugate having a cleavable linkage for use in a liposome |
| 11/15/2001 | WO2000051582A3 Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron |
| 11/15/2001 | WO2000048574A9 Elegant film coating system |
| 11/15/2001 | US20010041920 Ambulatory medical apparatus and method having telemetry modifiable control software |
| 11/15/2001 | US20010041831 Ambulatory medical apparatus and method having telemetry modifiable control software |
| 11/15/2001 | US20010041824 Implantable delivery system and method for the pharmacologic management of erectile dysfunction |